AKT1 and breast carcinoma: Several signaling pathways have been demonstrated to enhance proliferative of breast cancer cells, including the activation of JAK/STAT3 and PI3K/Akt by leptin, as well as JAK2 activation-mediated human epidermal growth factor receptor-2 (HER2) transactivation (106, 107).